Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sadaf Pakdaman

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cytokine|September 13, 2020
Cytokine changes in sickle-cell disease patients as markers predictive of the onset of delayed hemolytic transfusion reactionsPhilippe Chadebech, Marie-Amélie de Ménorval, Gwellaouen Bodivit, et al.
European Journal of Immunology|March 13, 2015
Phenotypic differences of CD4(+) T cells in response to red blood cell immunization in transfused sickle cell disease patientsBenoît Vingert, Marie Tamagne, Anoosha Habibi, et al.
American Journal of Hematology|April 30, 2014
Partial dysfunction of Treg activation in sickle cell diseaseBenoît Vingert, Marie Tamagne, Maxime Desmarets, et al.
American Journal of Hematology|January 29, 2020
Complement activation in sickle cell disease: Dependence on cell density, hemolysis and modulation by hydroxyurea therapyLubka T Roumenina, Philippe Chadebech, Gwellaouen Bodivit, et al.
American Journal of Hematology|July 19, 2020
Individual red blood cell fetal hemoglobin quantification allows to determine protective thresholds in sickle cell diseaseNicolas Hebert, Marie Georgine Rakotoson, Gwellaouen Bodivit, et al.
Transfusion|January 31, 2026
Carbon monoxide treatment rescues leukofiltration and preserves storage quality of red blood cell concentrates from sickle cell trait donorsSofiane Driouche, Laurent Kiger, Stephane Moutereau, et al.
Haematologica|March 31, 2022
Preclinical evaluation of the preservation of red blood cell concentrates by hypoxic storage technology for transfusion in sickle cell diseaseLaura Bencheikh, Kim-Anh Nguyen, Philippe Chadebech, et al.
Blood|September 14, 2017
Nonclassical <i>FCGR2C</i> haplotype is associated with protection from red blood cell alloimmunization in sickle cell diseaseSanne M Meinderts, Joep W R Sins, Karin Fijnvandraat, et al.
Haematologica|November 2, 2020
Anti-C5 antibody treatment for delayed hemolytic transfusion reactions in sickle cell diseaseAline Floch, Alexandre Morel, Fabian Zanchetta-Balint, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cytokine|September 13, 2020
Cytokine changes in sickle-cell disease patients as markers predictive of the onset of delayed hemolytic transfusion reactionsPhilippe Chadebech, Marie-Amélie de Ménorval, Gwellaouen Bodivit, et al.
European Journal of Immunology|March 13, 2015
Phenotypic differences of CD4(+) T cells in response to red blood cell immunization in transfused sickle cell disease patientsBenoît Vingert, Marie Tamagne, Anoosha Habibi, et al.
American Journal of Hematology|April 30, 2014
Partial dysfunction of Treg activation in sickle cell diseaseBenoît Vingert, Marie Tamagne, Maxime Desmarets, et al.
American Journal of Hematology|January 29, 2020
Complement activation in sickle cell disease: Dependence on cell density, hemolysis and modulation by hydroxyurea therapyLubka T Roumenina, Philippe Chadebech, Gwellaouen Bodivit, et al.
American Journal of Hematology|July 19, 2020
Individual red blood cell fetal hemoglobin quantification allows to determine protective thresholds in sickle cell diseaseNicolas Hebert, Marie Georgine Rakotoson, Gwellaouen Bodivit, et al.
Transfusion|January 31, 2026
Carbon monoxide treatment rescues leukofiltration and preserves storage quality of red blood cell concentrates from sickle cell trait donorsSofiane Driouche, Laurent Kiger, Stephane Moutereau, et al.
Haematologica|March 31, 2022
Preclinical evaluation of the preservation of red blood cell concentrates by hypoxic storage technology for transfusion in sickle cell diseaseLaura Bencheikh, Kim-Anh Nguyen, Philippe Chadebech, et al.
Blood|September 14, 2017
Nonclassical <i>FCGR2C</i> haplotype is associated with protection from red blood cell alloimmunization in sickle cell diseaseSanne M Meinderts, Joep W R Sins, Karin Fijnvandraat, et al.
Haematologica|November 2, 2020
Anti-C5 antibody treatment for delayed hemolytic transfusion reactions in sickle cell diseaseAline Floch, Alexandre Morel, Fabian Zanchetta-Balint, et al.
Pageof 2